Minon J.M., Gerard C., Dricot J.F., et al. New approaches to prenatal diagnosis of rhesus incompatibility. Rev Med Liege 2006, 61:756-762.
Ziprin J.H., Payne E., Hamidi L., et al. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia. Transfus Med 2005, 15:57-60.
Wang M., Hays T., Ambruso D.R., et al. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother. Pediatr Blood Cancer 2005, 45:861-862.
Newman T.B., Liljestrand P., Jeremy R.J., et al. Outcomes among newborns with total serum bilirubin levels of 25mg per deciliter or more. N Engl J Med 2006, 354:1889-1900.
Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297-316. American Academy of Pediatrics.
Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary. Paediatr Child Health 2007, 12:401-418. Canadian Paediatric Society and Fetus and Newborn Committee.
McDonnell M., Hannam S., Devane S.P. Hydrops fetalis due to ABO incompatibility. Arch Dis Child Fetal Neonatal Ed 1998, 78:F220-F221.
Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Paediatr Child Health 2005, 41:504-507.
Herschel M., Karrison T., Wen M., et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics 2002, 110:127-130.
Madan A., MacMahon J.R., Stevenson D.K., et al. Neonatal hyperbilirubinemia. Avery's Diseases of the Newborn 2005, Elsevier Saunders, Philadelphia, p. 1226-56. H.W. Taeusch, R.A. Ballard, C.A. Gleason (Eds.).
Maisels M.J., McDonagh A.F. Phototherapy for neonatal jaundice. N Engl J Med 2008, 358:920-928.
Yaseen H., Khalaf M., Rashid N., et al. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?. J Perinatol 2005, 25:590-594.
Monpoux F., Dageville C., Maillotte S., et al. Immunoglobulines polyvalentes intraveineuses et ictère néonatal par allo-immunisation érythrocytaire. Arch Pediatr 2009, 16:1289-1294.
Gottstein R., Cooke R.W. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003, 88:F6-F10.
Miqdad A.M., Abdelbasit O.B., Shaheed M.M., et al. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med 2004, 16:163-166.
Navarro M., Negre S., Matoses M.L., et al. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Pediatr 2009, 98:1214-1217.
Senterre T., Viellevoye R., Rigo J. Complications et recommandations d'utilisation des immunoglobulines intraveineuses en cas de maladie hémolytique allo-immune du nouveau-né. Arch Pediatr 2010, 17:299-300.
Figueras-Aloy J., Rodriguez-Miguèlez J.M., Iriondo-Sanz M., et al. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with haemolytic disease. Pediatrics 2010, 125:139-144.
